jeannette-brock-lynda-wharton


Two interviews with Jeannette Brock, an ACC Advocate. Excellent info for you or someone you know who has been injured. Also information to consider before you decide on the experimental mRNA injection. TWNZ

VIDEO LINK TO INTERVIEW ... LYNDA WHARTON SPEAKS WITH ACC ADVOCATE, JEANNETTE BROCK:

https://www.facebook.com/lyndawhartonhome/videos/239088914918851/

The information below is from an OIA to ACC..
Claim lodgement rates are dependent on several factors. They can be influenced by:
• Population demography i.e the characteristics of the resident population, visitors and referred
patients
• Health status of the population treated
• What level of facility the organisation provides i.e tertiary versus secondary
• Familiarity of health providers or clients in recognising and/or lodging treatment injury claims
Covid-19 vaccine related treatment injury claims
The data below was extracted on 18 October 2021, for treatment injury claims where the treatment event was vaccination or injection/medications, adverse reaction/medication error and where the medication type was recorded as vaccine.
However, as these fields are only completed when cover for the claim is decided, the figures provided have been supplemented by a text search of the claim forms received by ACC which mention Comirnaty (the name of the Pfizer-BioNTech COVID-19 vaccine) or included the terms covid or Pfizer and vacc. This text search allows us to identify claims that have been lodged but where cover has not been decided.
Please note that we can only respond based on the vaccine related claims lodged with ACC, and the figures may differ to those previously reported or supplied. Up-to-date data on the number of adverse effects reported from the COVID-19 vaccine can be found on the MedSafe website, here.
TI claims related to the Comirnaty vaccine
Comirnaty is the only COVID-19 vaccine that has been used as part of New Zealand’s vaccination response. With the exception of fewer than four cases where the vaccine was administered abroad and ACC does not have certainty over the vaccine used, all figures quoted in this response are assumed to be in relation to the Pfizer-BioNTech Comirnaty vaccine.
Between 18 February 2021 (when New Zealand began COVID vaccinations) and 16 October 2021, ACC has received 684 claims for injuries relating to the COVID-19 vaccination. Of these, 260 claims have been accepted, 123 have been declined and 301 are yet to be decided. As at 18 October 2021, no claims for fatalities in relation to the COVID-19 vaccination had been lodged with ACC. The table below provides the count of accepted COVID-19 vaccination claims, by primary injury.
TI claims related to the COVID-19 vaccine, by primary injury
Allergic Reaction 75 Anaphylactic Reaction* 25 Adverse Drug Reaction 24 Cellulitis 7 Cardiac injury 7 Contusion 6 Wound Infection 6 Nerve Damage 4 Infection 4 Other Specified 17 Other Unspecified 85 Total 260
* All cases identified as anaphylactic reactions were accepted.
GOV-014620
Primary Injury
All Accepted Claims
Accident Compensation Corporation
Page 2 of 3
TAKE HOME STORY....ONLY A TINY FRACTION OF THE INJURED OR BEREAVED ARE APPLYING FOR ACC COVER.
PEOPLE CLEARLY DONT KNOW THIS IS EVEN A POSSIBILITY
 
RELATED:
A LINK BELOW TO ANOTHER INTERVIEW, THIS TIME JEANNETTE SPEAKS WITH LEIGHTON BAKER:

Comments powered by CComment

Joomla Social by OrdaSoft!